Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
KLOW is a multi-peptide research formulation combining BPC-157, TB-500 (Thymosin Beta-4 fragment), GHK-Cu, and KPV, commonly examined in laboratory environments for their collective influence on cellular signaling pathways related to tissue response and inflammatory modulation
Typical REGEN protocols run 4-8 weeks for acute injuries, 8-12 weeks for chronic conditions, and 4-6 weeks for athletic recovery and maintenance
Specifications: Unit Size: 10mg (lyophilized powder, single vial) Molecular Formula: CHNO Molecular Weight: ~1419.5 Da Form: Lyophilized powder Storage: Store lyophilized peptide at 2C8C in a cool, dark place
Protocol 3: Comprehensive approach (advanced, with medical supervision) Goal: Full-spectrum immune modulation with organ support Phase 1 (Weeks 1-4): Foundation Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly BPC-157: 300 mcg subcutaneously, twice daily Phase 2 (Weeks 5-12): Add modulation Continue Phase 1 peptides Add KPV: 300-500 mcg subcutaneously, once daily Add Selank: 500 mcg intranasally, once daily Phase 3 (Weeks 13-16): Organ support cycle Continue Phase 2 peptides Add Thymalin: 10 mg course over 10 days Add targeted bioregulators based on affected organs (kidney, cardiac, vascular as needed) Phase 4 (Weeks 17-20): Rest and assess Discontinue all peptides Monitor disease activity markers Assess sustained benefits Plan next cycle based on results Monitoring: Full labs every 4 weeks, including CBC, CMP, complement levels, anti-dsDNA, CRP, ESR, urine protein/creatinine ratio
Any form of introduction into the human or animal body is illegal.
Both modifications are studied in vitro for the resistance they confer to exopeptidase cleavage and for their effect on measured peptide half-life in serum-stability assays
US$ 29.85
US$ 22.79
US$ 29.65
US$ 25.54
US$ 24.79
US$ 24.42
